Merus (MRUS) Competitor Comparison
We are evaluating the key criteria listed to compare Merus (MRUS) against its competitors in the Biotechnology industry.
Market Capitalization
61 / 368Gross Profits
241 / 278Total Revenue
129 / 300EBITDA
259 / 337Free Cashflow
264 / 352Quick Ratio
152 / 357Earnings per Share
284 / 359Dividend yield
0 / 6Total Cash
77 / 358Performance 3 years
49 / 368Performance 5 years
40 / 368Performance 10 years
22 / 368Linearity 3 years
314 / 368Linearity 5 years
355 / 368Linearity 10 years
357 / 368Total Rank
335 / 368Dividend Rank
203 / 368Valuation Rank
144 / 368Piotroski Rank
358 / 368Muliplier Rank
155 / 368Dividend yield - MRUS ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.